|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-1-26
|
|
pubmed:abstractText |
Despite improvements in the surgical management of esophageal cancer, the prognosis of patients with lymph node metastases is still unsatisfactory. Recently, survival benefit of neoadjuvant or induction chemotherapy for patients with esophageal cancer has been highlighted.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9867
|
|
pubmed:author |
pubmed-author:BabaHideoH,
pubmed-author:BabaYoshifumiY,
pubmed-author:HayashiNaokoN,
pubmed-author:HirashimaKotaroK,
pubmed-author:HiyoshiYukiharuY,
pubmed-author:ImamuraYuY,
pubmed-author:IwagamiShiroS,
pubmed-author:IwatsukiMasaakiM,
pubmed-author:KarashimaRyuichiR,
pubmed-author:KinoshitaKuichiK,
pubmed-author:KurashigeJunjiJ,
pubmed-author:MiyamotoYujiY,
pubmed-author:NagaiYoheiY,
pubmed-author:SaitoSeiyaS,
pubmed-author:SatoNobutakaN,
pubmed-author:WatanabeMasayukiM
|
|
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
146-52
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer.
|
|
pubmed:affiliation |
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
|
|
pubmed:publicationType |
Journal Article,
Review
|
